News

: Biotech stocks had a challenging year, but that doesn’t mean they’re ‘necessarily on sale,’ J&J exec tells investors

The comments made by a Johnson & Johnson executive earlier this week about biotechnology valuations calls attention to the struggling biotech sector.

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:News